Clontech Laboratories provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. Clontech, now part of the TaKara group,  is committed to improving the human condition through biotechnology. Clontech’s mission is to develop high-quality innovative tools and services to accelerate discovery. Clontech holds over 30 patents and offers novel tools for studying gene expression analysis, subcellular localization, apoptosis, and signal transduction.

Takara Bio Inc., is headquartered in Otsu, Shiga, Japan. Takara Bio was the first manufacturer to introduce restriction enzymes to the Japanese market in 1979, and it has consistently developed molecular biology products and technologies that draw upon the latest advances in genetic engineering. Takara Bio holds worldwide patents on Long and Accurate (LA) PCR, and has built a reputation for producing high-performance PCR reagents and kits, including Ex Taq™, LA Taq™, and Z-Taq™ DNA Polymerases.  Takara Bio's line of high-quality molecular biology reagents and kits includes restriction and modifying enzymes, kits for cloning and ligation of DNA, sequencing and mutagenesis, and high-efficiency gene transfer.

BioLegend develops and manufactures world-class, cutting-edge immunological, high quality reagents for biomedical research. The product areas include cell immunophenotyping, cytokines and chemokines, adhesion, cancer research, T regulatory cells, stem cells, innate immunity, cell-cycle analysis, apoptosis, and modification-specific antibodies.  The reagents produced can be used in a variety of applications including flow cytometry, ELISA, immunoprecipitation, Western blotting, immunofluorescence microscopy, immunohistochemistry, and in vitro or in vivo functional assays.

Since 1993 Macherey Nagel has successfully been developing and producing a wide range of ready-to-use kits and consumables for purification of nucleic acids (DNA and RNA) and proteins. They have a wide range of core technologies such as silica-based anion exchange (NucleoBond®), silica-based membrane technology (NucleoSpin®) or beads based on silica or latex (NucleoTrap®).   More recently, Macherey Nagel, introduced other technologies: ultrafiltration (NucleoFast), Magnetic Beads (NucleoMag), immobilised metal ion affinity chromatography (Protino) and gel filtration (NucleoSEQ).

Polyplus-transfection is focused on developing reagents for intracellular delivery of biomolecules. Its expertise includes in vitro and in vivo delivery of genes, oligonucleotides, siRNA and proteins. Polyplus is an established, reliable partner to researchers in academic, biotech and pharmaceutical laboratories. The company owns exclusive rights over the cationic macromolecule polyethylenimine (PEI) and its derivatives, a discovery made at the Laboratoire de Chimie Génétique directed by Dr. J.P. Behr. jetPEI™ is a genuine, homemade compound, which is performance-certified.

Bio Basic Inc. is a privately owned dynamic biotechnology company. The company was founded in 1990 in Toronto, Canada. From 1990 to 1995, Bio Basic Inc.’s primary focus has been in the field of biochemicals. Starting in 1995, Bio Basic Inc. has begun manufacturing various Life Science Products. Throughout the past years, the company has developed rapidly and served as a one-stop-shop to our customers in the life sciences field. To date, Bio Basic Inc. has approximately 600 employees, seven laboratories, three factory buildings, 40 international distributors and over 10,000 customers worldwide.